Gladstone Institutional Advisory LLC Takes $204,000 Position in HCA Healthcare, Inc. (NYSE:HCA)

Posted by on Apr 22nd, 2023

Gladstone Institutional Advisory LLC purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Get Rating) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 850 shares of the company’s stock, valued at approximately $204,000.

Other institutional investors have also recently made changes to their positions in the company. RB Capital Management LLC lifted its stake in shares of HCA Healthcare by 25.9% in the 1st quarter. RB Capital Management LLC now owns 2,432 shares of the company’s stock worth $610,000 after purchasing an additional 501 shares during the period. American Century Companies Inc. lifted its stake in shares of HCA Healthcare by 18.6% in the 1st quarter. American Century Companies Inc. now owns 11,035 shares of the company’s stock worth $2,766,000 after purchasing an additional 1,730 shares during the period. Prudential PLC bought a new position in shares of HCA Healthcare in the 1st quarter worth approximately $1,083,000. Cetera Investment Advisers lifted its stake in shares of HCA Healthcare by 1.3% in the 1st quarter. Cetera Investment Advisers now owns 4,499 shares of the company’s stock worth $1,128,000 after purchasing an additional 56 shares during the period. Finally, Sequoia Financial Advisors LLC bought a new stake in HCA Healthcare during the 1st quarter worth approximately $248,000. Hedge funds and other institutional investors own 64.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the stock. Deutsche Bank Aktiengesellschaft raised their target price on shares of HCA Healthcare from $240.00 to $275.00 in a research note on Tuesday, January 3rd. Citigroup raised their target price on shares of HCA Healthcare from $280.00 to $293.00 and gave the stock a “buy” rating in a research note on Monday, January 30th. JPMorgan Chase & Co. raised their target price on shares of HCA Healthcare from $257.00 to $283.00 and gave the stock a “neutral” rating in a research note on Wednesday. Truist Financial increased their price objective on shares of HCA Healthcare from $270.00 to $290.00 and gave the company a “buy” rating in a report on Monday, January 30th. Finally, Wells Fargo & Company increased their price objective on shares of HCA Healthcare from $217.00 to $243.00 and gave the company an “equal weight” rating in a report on Tuesday, January 3rd. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $272.87.

Insider Activity at HCA Healthcare

In related news, CFO Bill B. Rutherford sold 30,000 shares of HCA Healthcare stock in a transaction dated Friday, February 3rd. The stock was sold at an average price of $258.19, for a total value of $7,745,700.00. Following the completion of the sale, the chief financial officer now directly owns 81,632 shares in the company, valued at $21,076,566.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other HCA Healthcare news, SVP Kathleen M. Whalen sold 1,734 shares of the business’s stock in a transaction dated Friday, February 17th. The shares were sold at an average price of $263.61, for a total value of $457,099.74. Following the completion of the transaction, the senior vice president now directly owns 9,962 shares in the company, valued at $2,626,082.82. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Bill B. Rutherford sold 30,000 shares of the stock in a transaction on Friday, February 3rd. The stock was sold at an average price of $258.19, for a total transaction of $7,745,700.00. Following the completion of the sale, the chief financial officer now owns 81,632 shares in the company, valued at approximately $21,076,566.08. The disclosure for this sale can be found here. Insiders sold 88,159 shares of company stock worth $22,688,959 over the last three months. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Stock Up 3.9 %

NYSE HCA opened at $281.21 on Friday. The company has a fifty day moving average of $258.39 and a two-hundred day moving average of $242.29. The firm has a market capitalization of $77.89 billion, a price-to-earnings ratio of 14.62, a PEG ratio of 1.94 and a beta of 1.64. HCA Healthcare, Inc. has a 52 week low of $164.47 and a 52 week high of $294.02.

HCA Healthcare (NYSE:HCA – Get Rating) last released its earnings results on Friday, January 27th. The company reported $4.64 earnings per share for the quarter, missing the consensus estimate of $4.79 by ($0.15). HCA Healthcare had a negative return on equity of 1,260.96% and a net margin of 9.37%. The business had revenue of $15.50 billion for the quarter, compared to the consensus estimate of $15.51 billion. Equities research analysts anticipate that HCA Healthcare, Inc. will post 17.18 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 30th. Investors of record on Friday, June 16th will be issued a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 0.85%. HCA Healthcare’s payout ratio is currently 12.48%.

HCA Healthcare declared that its Board of Directors has authorized a share repurchase program on Friday, January 27th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the company to buy up to 4.2% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company’s board believes its stock is undervalued.

About HCA Healthcare

(Get Rating)

HCA Healthcare, Inc is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities.

Featured Stories

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.